AVEO Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference

Press Release

View printer-friendly version

<<  Back

AVEO Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 27, 2012-- AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5, 2012 at 4:10 p.m. (EST) in Boston.

A live webcast of AVEO's presentation can be accessed by visiting the investors section of the company's website at investor.aveopharma.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation.

About AVEO

AVEO Pharmaceuticals (Nasdaq: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform™ provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveopharma.com.

Source: AVEO Pharmaceuticals

Investor Contact:
AVEO Pharmaceuticals, Inc.
Monique Allaire, 617-299-5810
or
Media Contact:
Pure Communications, Inc.
Caton Lovett, 910-232-7166